205 related articles for article (PubMed ID: 16571020)
1. Bioactive permethrin/beta-cyclodextrin inclusion complex.
Yang GF; Wang HB; Yang WC; Gao D; Zhan CG
J Phys Chem B; 2006 Apr; 110(13):7044-8. PubMed ID: 16571020
[TBL] [Abstract][Full Text] [Related]
2. Inclusion complexes of noscapine in beta-cyclodextrin offer better solubility and improved pharmacokinetics.
Madan J; Dhiman N; Parmar VK; Sardana S; Bharatam PV; Aneja R; Chandra R; Katyal A
Cancer Chemother Pharmacol; 2010 Feb; 65(3):537-48. PubMed ID: 19597818
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
[TBL] [Abstract][Full Text] [Related]
4. Formation of supramolecular permethrin/beta-cyclodextrin nanorods.
Yang GF; Wang HB; Yang WC; Gao D; Zhan CG
J Chem Phys; 2006 Sep; 125(11):111104. PubMed ID: 16999459
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the 13-cis-retinoic acid/cyclodextrin inclusion complexes by phase solubility, photostability, physicochemical and computational analysis.
Yap KL; Liu X; Thenmozhiyal JC; Ho PC
Eur J Pharm Sci; 2005 May; 25(1):49-56. PubMed ID: 15854800
[TBL] [Abstract][Full Text] [Related]
6. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
7. Assembly of beta-cyclodextrin with 3S-tetrahydro-beta-carboline-3-carboxylic acid and self-assembly of 6-(3'S-carboline-3'-carboxylaminoethylamino)-6-deoxy-beta-cyclodextrin: approaches to enhance anti-oxidation stability and anti-thrombotic potency.
Li L; Cui G; Zhao M; Wang Y; Wang H; Li W; Peng S
J Phys Chem B; 2008 Sep; 112(38):12139-47. PubMed ID: 18754637
[TBL] [Abstract][Full Text] [Related]
8. Study of the physicochemical properties of trimethoprim with beta-cyclodextrin in solution.
Li N; Zhang YH; Xiong XL; Li ZG; Jin XH; Wu YN
J Pharm Biomed Anal; 2005 Jun; 38(2):370-4. PubMed ID: 15925234
[TBL] [Abstract][Full Text] [Related]
9. [Study on measuring host-guest ratio of inclusion compound of beta-CD-permethrin by IR].
Shao QF; Dong M; Xie XH; Zeng LP; Leng LB
Guang Pu Xue Yu Guang Pu Fen Xi; 2004 Jun; 24(6):698-700. PubMed ID: 15766186
[TBL] [Abstract][Full Text] [Related]
10. Inclusion complex of trimethoprim with beta-cyclodextrin.
Li N; Zhang YH; Wu YN; Xiong XL; Zhang YH
J Pharm Biomed Anal; 2005 Sep; 39(3-4):824-9. PubMed ID: 16011886
[TBL] [Abstract][Full Text] [Related]
11. Evidence for the 2:1 molecular recognition and inclusion behaviour between beta- and gamma-cyclodextrins and cinchonine.
Wen X; Liu Z; Zhu T; Zhu M; Jiang K; Huang Q
Bioorg Chem; 2004 Aug; 32(4):223-33. PubMed ID: 15210337
[TBL] [Abstract][Full Text] [Related]
12. Structure elucidation of the tetrahydrocannabinol complex with randomly methylated beta-cyclodextrin.
Hazekamp A; Verpoorte R
Eur J Pharm Sci; 2006 Dec; 29(5):340-7. PubMed ID: 16934442
[TBL] [Abstract][Full Text] [Related]
13. Formation of natamycin:cyclodextrin inclusion complexes and their characterization.
Koontz JL; Marcy JE
J Agric Food Chem; 2003 Nov; 51(24):7106-10. PubMed ID: 14611179
[TBL] [Abstract][Full Text] [Related]
14. Effect of pH and water-soluble polymers on the aqueous solubility of nimesulide in the absence and presence of beta-cyclodextrin derivatives.
Alexanian C; Papademou H; Vertzoni M; Archontaki H; Valsami G
J Pharm Pharmacol; 2008 Nov; 60(11):1433-9. PubMed ID: 18957163
[TBL] [Abstract][Full Text] [Related]
15. Isothermal titration calorimetry and 1H NMR studies on host-guest interaction of paeonol and two of its isomers with beta-cyclodextrin.
Sun DZ; Li L; Qiu XM; Liu F; Yin BL
Int J Pharm; 2006 Jun; 316(1-2):7-13. PubMed ID: 16554127
[TBL] [Abstract][Full Text] [Related]
16. Inclusion complexes of pyrimethamine in 2-hydroxypropyl-beta-cyclodextrin: characterization, phase solubility and molecular modelling.
de Araújo MV; Vieira EK; Lázaro GS; de Souza Conegero L; Ferreira OP; Almeida LS; Barreto LS; da Costa NB; Gimenez IF
Bioorg Med Chem; 2007 Sep; 15(17):5752-9. PubMed ID: 17583516
[TBL] [Abstract][Full Text] [Related]
17. Complexation of tanshinone IIA with 2-hydroxypropyl-beta-cyclodextrin: effect on aqueous solubility, dissolution rate, and intestinal absorption behavior in rats.
Wang L; Jiang X; Xu W; Li C
Int J Pharm; 2007 Aug; 341(1-2):58-67. PubMed ID: 17482783
[TBL] [Abstract][Full Text] [Related]
18. Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrin.
Liu J; Qiu L; Gao J; Jin Y
Int J Pharm; 2006 Apr; 312(1-2):137-43. PubMed ID: 16459034
[TBL] [Abstract][Full Text] [Related]
19. Dissolution properties and characterization of halofantrine-2-hydroxypropyl-beta-cyclodextrin binary systems.
Onyeji CO; Omoruyi SI; Oladimeji FA
Pharmazie; 2007 Nov; 62(11):858-63. PubMed ID: 18065103
[TBL] [Abstract][Full Text] [Related]
20. Preparation and spectral investigation of inclusion complex of caffeic acid with hydroxypropyl-beta-cyclodextrin.
Zhang M; Li J; Zhang L; Chao J
Spectrochim Acta A Mol Biomol Spectrosc; 2009 Jan; 71(5):1891-5. PubMed ID: 18722807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]